In sorrow thou shalt bring forth children (Genesis 3:16) seems as relevant today, with one of seven mothers afflicted by a depressive episode, constituting the most common medical complication after delivery. Why mothers are variably affected by mood symptoms postpartum remains unclear, and the pathogenesis and early molecular indicators of this divergent outcome have not been described. We applied a case-control design comparing differential global gene expression profiles in blood mononuclear cells sampled shortly after delivery at the time of inception of postpartum depression (PD). Nine antidepressant naive mothers showing high depressive scores and developing a persisting major depressive episode with postpartum onset were compared with 10 mothers showing low depressive scores and no depressive symptoms on prospective follow-up. A distinctive gene expression signature was observed after delivery among mothers with an emergent PD, with a significant overabundance of transcripts showing a high-fold differential expression between groups, and correlating with depressive symptom severity among all mothers. Early expression signatures correctly classified the majority of PD patients and controls. Those developing persisting PD exhibit a relative downregulation of transcription after delivery, with differential immune activation, and decreased transcriptional engagement in cell proliferation, and DNA replication and repair processes. Our data provide initial evidence indicating that blood cells sampled shortly after delivery may harbor valuable prognostic information for identifying the onset of persisting PD. Some of the informative transcripts and pathways may be implicated in the differential vulnerability that underlies depression pathogenesis.
Introduction
The immediate period after delivery is noted for a significant increase in risk for psychiatric disorders. 1 Most commonly, the incidence of depression impairing maternal functioning is increased, affecting 14.5% of mothers after delivery. 2 A postpartum precipitous drop of reproductive hormones and cortisol from high pregnancy levels has been proposed as a contributing underlying mechanism. 3 A comparison of the effect of simulated prototypical postpartum reproductive hormonal changes between euthymic mothers with or without an earlier history of postpartum depression (PD) has uncovered a differential latent vulnerability for manifesting reactive depressive symptoms, only among those who suffered an earlier PD. 3 Similar hormonal challenge strategies applied to rats showed behavioral phenotypes relevant to PD, [4] [5] [6] as well as accompanying gene expression changes in the dentate gyrus. 6 Twin data support a modest heritability for unipolar depression, 7 with a higher overall heritability for women, which includes in part gender-specific factors. 8 Locating the actual molecular processes mediating this heritable predisposition is hindered by a low specificity of the broadly defined unipolar depressive phenotypic syndrome 9 and lack of timely access to relevant brain regions. A modest heritable contribution has also been more specifically shown for postpartum depressive symptoms, 10 and increased familial aggregation has been shown for PD onset shortly after delivery, suggesting that an early-onset PD phenotype possesses higher specificity for biological studies. 11 The application of high-throughput gene expression profiling to neuropsychiatric disorders in humans has mostly been restricted to postmortem brain tissue, typically sampled many decades after the critical time frame during which the initial molecular processes underlying the onset and development of disease have occurred, with methodological challenges including decades of cumulative drug exposure and postmortem artifacts. [12] [13] [14] Indeed, a recent postmortem brain study that applied separate analyses of samples derived from schizophrenia patients at different stages of illness showed an inverse correlation between the proportion of transcripts found to show a schizophrenia-related differential expression and duration of illness, suggesting that sampling at an early stage after illness onset may be most informative for locating disease-associated differential expression signatures. 15 In an attempt to circumvent some of the postmortem-related limitations, recent studies have reported informative white cell gene expression signatures among neuropsychiatric disorders, including bipolar disorder and schizophrenia, [16] [17] [18] [19] [20] [21] and autism. 22, 23 Some of the differentially expressed genes have been proposed to possess pathogenetic relevance. 24, 25 Sampling surrogate mononuclear cells allows access to freshly isolated systemic cellular reactivity during a clinically relevant time window among carefully selected homogenous samples of patients. Most studies to date have measured peripheral blood mononuclear cell (PBMC) gene expression levels at baseline or in lymphoblastoid cell lines derived from chronic drug-treated patients, which may not grapple the full potential of this methodology. Gene transcription is a reactive intermediate phenotype that may capture the transient genomic response to a stimulus (such as transcriptional reactivity to an inflammatory stimulus challenge 26 or after ischemic stroke 27 ). Comparing transcriptional response to a common in vitro stimulus between patient and control cells may uncover a disease-related differential reactivity, such as an abnormal T-cell response to immune challenge among schizophrenics, 28 or a differential transcriptional reactivity to glucose deprivation among individuals with bipolar disorder. 29 Moreover, differential PBMC transcriptional patterns may be informative of divergent individual clinical outcomes in response to a common clinical intervention or trigger. Informative in vivo PBMC expression reactivity has been previously documented to accompany differential clinical outcomes after exposure to a common factor for a range of clinical disorders including allograft tolerance, 30 glucocorticoid resistance among asthma patients 31 and response to trauma among survivors who develop posttraumatic stress disorder. 32 The triggering of depression during the immediate postpartum period presents a critical time window for the search of differential expression reactivity among women exhibiting divergent clinical outcomes on prospective follow-up. Mood changes affecting mothers after delivery are notable for a spectrum of severity and time course, with up to one in two demonstrating self-contained minor depressive symptoms (blues) that resolve within the first 3 weeks, 33 and one in seven going on to develop a functionally impairing depressive episode. 2 We applied a casecontrol design, sampling blood from mothers shortly after delivery and comparing PBMC gene expression profiles between those with high depressive scores at the time of sampling, who went on to develop a fullblown major depressive episode on prospective follow-up, and those with the lowest depressive scores who remained well at follow-up. We found a significantly high number of gene transcripts showing differential expression among mothers who developed PD. Differential signatures distinguish the majority of mothers with emergent PD from healthy controls who remained well on prospective followup. Affected mothers show transcriptional alterations in immune activation, cell proliferation, chromatin assembly, nucleotide binding and DNA repair processes during the period immediately after delivery, which herald the onset of a persisting major depressive episode.
Materials and methods

Clinical procedure
To measure gene expression patterns that accompany the emergent PD episode, mothers were assessed after delivery and followed up prospectively applying a case-control design. To increase the likelihood of observing transcriptional differences, a temporally homogeneous cohort of mothers reporting a new onset of significant depressive symptoms by the second day postpartum and progressing to a major depressive episode by 6 weeks was contrasted with matched mothers scoring the lowest depressive scores after delivery and showing no depressive symptoms on prospective follow-up (see Supplementary Methods for detailed protocol).
Sample processing and analysis
Venous blood was collected shortly after delivery for determination of cell counts, and RNA was extracted from freshly separated PBMC and kept at À80 1C until use. A comparison of gene expression patterns was performed on cDNA derived from PBMC total RNA, and hybridized to GeneChip Human Exon 1.0 ST microarrays (Affymetrix, Santa Clara, CA, USA). Probe set signals were normalized using the PLIER algorithm with Expression Console 1.0 software (Affymetrix). Core set annotations were used for grouping of exons into gene level signals. A valid active subset of genes was identified upon which all calculations were performed. The general approach to analysis was outlined by Kaminski and Friedman 34 and performed using the ScoreGenes package (http:// compbio.cs.huji.ac.il/scoregenes/). To determine the significance of the number of high-fold differentially expressed gene transcripts, we applied a randomized permutation test with 1000 random reshuffling of subject labels. A Leave One Out cross Validation procedure was applied to further identify differentially expressed genes that remained robust to sequential perturbations of each of the samples. We next identified genes showing a significant Spearman's correlation with the day 2 Edinburgh Postnatal Depression Scale score among all participants. A random reshuffling of class labels with 1000 simulations was used to assess the significance of the number of correlated genes. Clustering was performed using Cluster package. 35 Principal component analysis was performed using Matlab version 7.1.0.183 (R14) (The MathWorks Inc., Natick, MA, USA). Functional annotations enrichment in the differential gene set was quantified using gene ontology (http://compbio.cgr.-harvard.edu/genesets/gene_sets.htm) by comparing the percentage of annotated transcripts in the differential gene set with their percentage in the active gene set. The P-value of annotation enrichment was calculated Figure 1 Analyses of differential transcriptional profiles between postpartum depression and controls. Shown are gene expression analyses of mothers developing postpartum major depression (PD, n = 9) and low-scoring control mothers (C, n = 10). (a) Overabundance plot evaluating the statistical significance of the number of genes that are differentially expressed between PD and control samples. A gene is defined as differentially expressed if exhibiting a significant t-test mean change between groups of 1.5-fold or more. Shown are only the genes that passed minimal-fold change criterion, ordered by t-test Pvalues. Red line denotes the number of differentially expressed genes that separate depressed from control samples (y axis), which were scored a given t-test P-value (x axis) among genes showing > 1.5-fold change (FC); Dark gray line denotes the number of genes expected by chance with P-value derived from 1000 simulations with random reshuffling of individual labels; light gray area, the range of numbers of differentially expressed genes in the 95th percentile of 1000 random simulations. The dotted vertical line indicates the P-value of 0.05, the threshold for defining a gene as differentially expressed. A significant overabundance of differentially expressed genes is observed. (b) Unsupervised average linkage clustering with an uncentered correlation 35 of expression profiles using 57 differentially expressed genes that remained robust to a leave-one-out procedure (see Materials and methods for details). according to a hyper geometric distribution model, using Matlab software 7.1.0.183 (R14) (The MathWorks Inc.). Differentially expressed genes were manually assigned to functional categories by extracting curated gene ontology annotations. A detailed description of sample processing, data normalization and the statistical methods applied is available in Supplementary Methods.
Results
Immediate gene expression signatures identify emergent persisting PD A total of 10 PD patients and 10 age-matched lowscoring control mothers were ascertained for this study. Oligonucleotide microarrays (Human Gene Chip Exon ST 1.0, Affymetrix) were used to measure the PBMC gene expression signal. Of the 20 available samples, one did not meet quality control measures after hybridization and was excluded from further analysis, and the rest of the analyses were performed on the remaining 9 PD and 10 control samples. Demographic and clinical variables (Supplementary Table 1 ), as well as total white cells and subset counts, did not show significant differences between the two groups (Supplementary Table 2 ). The mean day 2 Edinburgh Postnatal Depression Scale scores differed significantly between groups (PD: 10.2 þ 1.9; controls: 0.9 þ 0.7; t = 1.4 d.f.; P = 0.001) (Supplementary Table  1) . 17 PD patients and controls had no other current or past Axis I disorder, except for an untreated episode of PD in an earlier pregnancy that resolved spontaneously, reported by four of the PD patients. None of the participants reported a current or lifetime use of antidepressants or other psychotropic medications at the time of inclusion. The participants had no complicating medical conditions other than a longstanding hypothyroidism balanced on L-thyroxin in two of the PD patients and in two of the controls. After signal quantification and normalization, 3142 active gene transcripts were found to be expressed and showed some variance in mononuclear cells. We found a signature of 73 genes showing 1.5-fold or higher significant mean differences of P < 0.05 between patients and controls. The probability of observing such a number by chance, calculated using 1000 random permutations of the data, was found to be significantly lower than expression differences expected by chance in the randomly permutated raw data (P < 0.001) (Figure 1a) . To further examine the discriminatory potential of the expression signal, a Leave One Out cross Validation procedure was applied. A total of 57 of the above 73 differentially expressed transcripts remained significant after a consecutive removal of each of the 19 samples. When this set was subjected to a blind hierarchical clustering algorithm, 16 of 19 samples were correctly classified (Figure 1b) . In addition, principal components analysis using the 73 or 57 differential transcript sets (but not the 3142 active transcripts set) correctly distinguished PD patients and controls using the first two principal components (Figure 1c) . The full list of 73 differentially expressed genes is provided in Supplementary  Table 3 .
Gene expression profiles correlate with depressive symptoms score severity We next examined the correlation between the expression pattern of each gene and the continuous Edinburgh Postnatal Depression Scale scores measured on day 2 among all participants. We found 425 transcripts showing significant correlations with depressive symptom scores at day 2 at P < 0.05. This number, as well as the numbers of genes showing significant correlations at the different significance levels along the entire P-value distribution curve, was outside the 95% confidence interval expected by chance using 1000 random permutations of the data (Supplementary Figure 1) .
Differential PD signatures show a global reduction in transcription, distinct immune activation and decreased engagement in cell proliferation Our analyses identified a distinctive signature of genes differentially expressed shortly after delivery, which are informative of the emergence of persisting PD. To investigate the biological significance of these informative transcripts, we next examined their functional roles. A marked global reduction in transcription was observed among affected mothers, with 71 of 73 PD associated differentially expressed genes showing a reduced expression. Notably, we observed a decreased expression of genes related to transcriptional activation, cell cycle and proliferation, nucleotide binding, and DNA replication and repair processes (Figure 2a) . To quantify the enrichment of predefined pathways, percentages of gene ontology category annotations were calculated among the 73 differential genes and compared with their percentages among all 3142 active genes. A highly significant enrichment was observed in genes encoding several categories including cell cycle, chromatin assembly, DNA integrity checkpoint and immune response (Figure 2b) . A full list of significantly enriched categories is shown in Supplementary Table 4 .
Discussion
We found a distinctive gene expression signature in mononuclear cells sampled shortly after delivery, which correlates with the severity of depressive symptoms and predicts their long-term clinical course among psychotropic drug-naive symptomatic mothers who go on to develop persisting PD. The initial results presented suggest that a further comparison of additional phenotypic groups, such as transient depressive symptoms (postpartum blues), may be of considerable interest (to investigate transcriptional correlates of self-contained depressive reaction), and also the investigation of a later onset of depression. This would allow extending the assessment of the extent to which PBMC expression data may specifically relate to the evolution of the postnatal affective phenotypic spectrum.
Differential expression patterns among mononuclear cells at the outset of a PD episode may result from PBMC transcriptional reactivity to altered humoral signaling in the systemic circulation in depression, 36 the transcriptional impact of individual risk coffering genomic sequence variation shared with more relevant cell lines for some genes 24, [37] [38] [39] or a direct participation of the immune system in depression. 36, 40, 41 In as much as these last two factors may be operative, differential expression signatures may point to pathogenetically relevant underlying molecular processes, beyond possessing informative diagnostic and prognostic value.
Notwithstanding the fact that expression patterns in white cells cannot be taken to reliably predict expression patterns in the brain, 42 family data show a major heritable influence to baseline PBMC mRNA levels. 43 Mononuclear cells share the individual's unique DNA sequence variation, and trait-related baseline expression similarities may be observed across distant tissues such as neural cells, as described earlier for some transcripts. 24, [37] [38] [39] Mothers who develop persisting PD show a prominent reduction in transcriptional activation, as reflected by a reduced expression of the vast majority of differential transcripts. Interestingly, both posttraumatic stress disorder and PD seem to share prominent reductions of PBMC transcriptional activation during the immediate response to the provoking stressful trigger (trauma and delivery, respectively), which herald a persisting psychiatric sequel, although different transcripts are involved. 32 Several pathways are implicated here, including differential immune activation as reflected by a decreased expression of immune modulators, including several interferoninduced genes, as well as a decreased transcriptional engagement of genes related to cell cycle and DNA replication and repair among PD patients. Cellular proliferation and survival among neural and glial cells have been implicated in stress-and depressionrelated hippocampal volume depletion, and in some of the protective effects of antidepressant drugs. 44, 45 A general decrease in cell proliferation has been shown in the dentate gyrus as early as day 2 postpartum in rodents, 46, 47 and has been suggested to contribute to the observed increment in PD incidence. 47 It would be tempting to hypothesize that both the widespread and cell cycle-specific relative reductions in PBMC transcriptional responses observed here among PD patients may mirror a further PD-related accentuation of such a general postpartum temporal reduction in neural and glial cellular capacity for neurogenesis, which has been implicated as an underlying feature of depression pathogenesis. However, all that can be clearly deduced from this data is that the pathwayrelated transcriptional changes observed are robust enough to show a significant appearance among the heterogeneous mononuclear cell composition sampled. It remains to be established whether cellular pathway reactivity differences observed in PBMCs may represent a more pervasive cellular phenomena that further cross cellular boundaries to reverberate parallel reactivity occurring among more relevant central nervous system cell populations. A robust way to address the pathogenetic relevance of PDrelated PBMC transcriptional differences that bypass the need for timely access to brain cell postpartum reactivity is by screening for DNA sequence variation associations with differential PBMC transcriptional data and testing whether sequence variants shown to regulate PD-related PBMC differential transcripts indeed associate with PD risk among large PD casecontrol DNA samples.
To remove potential factors that may affect gene expression patterns, we excluded individuals with obstetric, medical or psychiatric disorders or drug treatment. The extensive physiological changes that take place postpartum likely affect gene expression patterns, but these should not differ between groups. Mononuclear cells extracted from whole blood include lymphocyte and monocyte subsets. The composition of circulating white cells could be altered in depression, 48 which might potentially contribute to group differences in the expression patterns observed here. Although unable to exclude such a possibility, we compared total and differential counts and found no significant differences for the major white cell subsets between groups. Notably, if a single mononuclear cell subpopulation displays PD-related transcriptional differences that are not shared by other mononuclear cell subtypes, these should be averaged, with a consequent reduction in the observed amplitude of the difference between groups. Such averaging may generally tend to muffle fold changes and significance levels and may increase false-negative results in the data. The PD-related transcriptional differences observed are therefore either robust enough to be apparent beyond such possible subpopulation differences within PBMCs or cross cellular boundaries and are shared by the different mononuclear cell subpopulations sampled. Refining mononuclear cell subsets comparisons using flow cytometry or concentrating on single-cell populations will increase the accuracy of results by reducing possible subpopulation differences in gene expression patterns. However, there is no compelling a priori rationale to guide focus on a certain mononuclear subpopulation for the study of PD, and isolation methods impose inherent artifacts related to the removal and prolonged manipulation of cells in vitro (for example, through magnetic cell sorting or Epstein Barr Virus transformation of lymphoblastoid cells). Prolonged incubation in room temperature has been found to exert dramatic effects on white blood cell gene expression. 49 We therefore chose in this study to examine freshly harvested cells, providing a snap shot of their endogenous reactivity during a clinically relevant physiological time window, thus minimizing in vitro manipulation and the duration of handling in room temperature.
We provide initial evidence that PBMCs sampled shortly after delivery at the time of triggering of a major depressive episode exhibit a distinct transcriptional profile that is informative of long-term clinical outcome. The results presented are limited by a modest sample size, and require a definitive replication in independent samples. Our results extend earlier research pointing to informative differential transcriptional reactivity in PBMCs for clinical outcome prediction of diverse organ-related disorders. 31, 32, 37, [50] [51] [52] [53] Additional studies are required to confirm predictive utility and examine pathogenetic implications of the differential peripheral signatures observed in PD, and extend these to other neuropsychiatric disorders.
